Sanifit appoints Cris Calsada as CFOLaboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced the appointment of Cris Calsada as Chief Financial Officer. more ➔
Targovax appoints Michael Bogenstaetter...Targovax ASA (OSE: TRVX) announces that Michael Bogenstaetter has been appointed as the Company’s Chief Business Officer (CBO). He will take up this role in January 2018. more ➔
Sally Ann Forsyth to join SBCStevenage Bioscience Catalyst (SBC) has announced that Dr. Sally Ann Forsyth is set to join the company as CEO in March 2018. more ➔
Avillion names new Chief Business OfficerLate-stage pharmaceuticals financing and co-development specialist Avillion LLP has named Kathryn J. Gregory Chief Business Officer. more ➔
Jesper Ericsson named new Chief Executiv...Symcel announced that Jesper Ericsson has joined Symcel as Chief Executive Officer. more ➔
MDx Health hires Michael Brawer as CMOBelgian diagnostics company MDxHealth SA has appointed Michael K. Brawer, MD as Chief Medical Officer to prepare the company for growth in H2/17 and beyond. The urologist and former professor of … more ➔
New CFO for Pharmalink Swedish specialty pharmaceutical company Pharmalink AB Stockholm has Fredrik Johansson as new Chief Financial Officer. more ➔
Orchard Therapeutics appoints Mark Rothe...Gene therapy specialist Orchard Therapeutics (London) has appointed Mark Rothera as President and Chief Executive Officer, a specialist for the commercialisation of novel treatments and business dev … more ➔
Uniqure’s new COO to oversee GMPGene therapy specialist Uniqure NV announced new executive appointments to its leadership team and nominations to its Board of Directors. Scott McMillan, for instance, will be responsible for all current … more ➔
Autolus: Accelerating T-cell productsIn preparation for the development and commercialisation of Autolus’ T-cell products, the London based company announced four new senior leadership appointments. more ➔
